Comparison of the effect of intracameral moxifloxacin, levofloxacin and cefazolin on rabbit corneal endothelial cells

Clinical and Experimental Ophthalmology

Volumn 36, Issue 4, 2008, Pages 367-370

  Kim, Su Young ^a,b   Park, Young Hoon ^a   Lee, Young Chun ^a  

^a The Catholic University of Korea   (South Korea)

^b Uijeongbu St Mary's Hospital   (South Korea)

Author keywords

Cornea; Effect; Endothelium; Intracameral antibiotics; Toxicity

Indexed keywords

CEFAZOLIN; LEVOFLOXACIN; MOXIFLOXACIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA THICKNESS; DRUG SAFETY; ENDOTHELIUM CELL; NONHUMAN; RABBIT; SCANNING ELECTRON MICROSCOPY; SPECULAR MICROSCOPY; TOXICITY TESTING;

ANIMALS; ANTERIOR CHAMBER; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; CEFAZOLIN; CELL COUNT; CORNEA; ENDOTHELIUM, CORNEAL; INJECTIONS; MICROSCOPY, ELECTRON, SCANNING; OFLOXACIN; QUINOLINES; RABBITS;

EID: 47649102532     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2008.01771.x     Document Type: Article

References (16)

1. Romero P, Méndez I, Salvat M, Fernández J, Almena M. Intracameral cefazolin as prophylaxis against endophthalmitis in cataract surgery. J Cataract Refract Surg 2006; 32: 438-41.
2. Maloof A, Saw V. Prophylactic intracameral vancomycin. J Cataract Refract Surg 2004; 30: 1610-11.
3. Montan PG, Wejde G, Koranyi G, Rylander M. Prophylactic intracameral cefuroxime; efficacy in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg 2002; 28: 1977-81.
4. Espiritu CR, Caparas VL, Bolinao JG. Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients. J Cataract Refract Surg 2007; 33: 63-8.
5. Kowalski RP, Dhaliwal DK, Karenchak LM et al. Gatifloxacin and moxifloxacin: An in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol 2003; 136: 500-5.
6. Burka JM, Bower KS, Vanroekel RC, Stutzman RD, Kuzmowych CP, Howard RS. The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy. Am J Ophthalmol 2005; 140: 83-7.
7. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: New weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 2002; 133: 463-6.
8. Kaufman AH, Baum J. Penicillins and cephalosporins. In: Zimmerrman TJ, ed. Textbook of Ocular Pharmacology. Philadelphia, PA: Lippincott-Raven, 1997; 473-91.
9. Peyman GA, Sathar ML, May DR. Intraocular gentamicin as intraoperative prophylaxis in South India eye camps. Br J Ophthalmol 1977; 61: 260-2.
10. Barry P, Seal DV, Gettinby G, Lees F, Peterson M, Revie CW, ESCRS Endophthalmitis Study. G ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study. J Cataract Refract Surg 2006; 32: 407-10.
11. Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model. Am J Ophthalmol 2005; 140: 497-504.
12. Kodjikian L, Garweg JG. Intracameral Vigamox (moxifloxacin 0.5%) is not effective in preventing endophthalmitis in a rabbit model. Am J Ophthalmol 2006; 141: 777; author reply -777 -8.
13. Gills JP. Filter and antibiotics in irrigating solution for cataract surgery. J Cataract Refract Surg 1991; 17: 385.
14. Gimbel HV, Sun R. Prophylactic intracameral vancomycin and CME [letter]. Ophthalmology 2000; 107: 1614-15.
15. Axer-Siegel R, Stiebel-Kalish H, Rosenblatt I, Strassmann E, Yassur Y, Weinberger D. Cystoid macular edema after cataract surgery with intraocular vancomycin. Ophthalmology 1999; 106: 1660-4.
16. Mamalis N, Edelhauser HF, Dawson DG, Chew J, LeBoyer RM, Werner L. Toxic anterior segment syndrome. J Cataract Refract Surg 2006; 32: 324-33.